A One-Generation Reproductive Toxicity Study of 3,4-Methylenedioxy-N-Methamphetamine (MDMA, Ecstasy), an Amphetamine Derivative, in C57BL/6 Mice

REFERENCES

• Angoa-Pérez, M., Kane, M. J., Briggs, D. I., Francescutti, D. M., Sykes, C. E., Shah, M. M., Thomas, D. M., and Kuhn, D. M. 2013. Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA. J. Neurochem. 125: 102–110.
   PubMed Web of Science ®Google Scholar
• Armenian, P., Mamantov, T. M., Tsutaoka, B. T., Gerona, R. R., Silman, E. F., Wu, A. H., and Olson, K. R. 2013. Multiple MDMA (Ecstasy) overdoses at a rave event: A case series. J. Intensive Care Med. 28: 252–258.
   PubMedGoogle Scholar
• Battaglia, G., Zaczek, R., and De Souza, E. B. 1990. MDMA effects in brain: Pharmacologic profile and evidence of neurotoxicity from neurochemical and autoradiographic studies. In Ecstasy: The clinical, pharmacological and neurological effects of the drug MDMA, ed. S. J. Peroutka, 171–199. Kluwer Academic Publishers; Norwell, MA, USA.
   Google Scholar
• Bronson, M. E., Jiang, W., Clark, C. R., and DeRuiter, J. 1994. Effects of designer drugs on the chicken embryo and 1-day-old chicken. Brain Res. Bull. 34: 143–150.
   PubMed Web of Science ®Google Scholar
• Cho, A. K., Hiramatsu, M., Distefano, E. W., Chang, A. S., and Jenden, D. J. 1990. Stereochemical differences in the metabolism of 3,4-methylenedioxymethamphetamine in vivo and in vitro: A pharmacokinetic analysis. Drug Metab. Dispos. 18: 686–691.
   PubMed Web of Science ®Google Scholar
• Cohen, C., Perrault, G., and Sanger, D. J. 1997. Assessment of the antidepressant-like effects of L-type voltage-dependent channel modulators. Behav.Pharmacol. 8: 629–638.
   PubMed Web of Science ®Google Scholar
• Cohen, R. S. 1998. The love drug. Marching to the beat of ecstasy. Binghamton, NY: Haworth Medical Press.
   Google Scholar
• Davis, W. M., and Borne, R. F. 1984. Pharmacologic investigation of compounds related to 3,4-methylenedioxyamphetamine (MDA). Subst. Alcohol Actions Misuse 5: 105–110.
   PubMedGoogle Scholar
• Davison, D., and Parrott, A. C. 1997. Ecstasy (MDMA) in recreational users: Self-reported psychological and physiological effects. Hum. Psychopharmacol. 12: 221–226.
   Web of Science ®Google Scholar
• Dawson, A. B. 1926. A note on the staining of the skeleton of cleared specimens with Alizarin red-S. Biotech. Histochem. 1: 123–124.
   Google Scholar
• De La Torre, R., Farré, M., Ortuño, J., Mas, M., Brenneisen, R., Roset, P. N., Segura, J., and Cami, J. 2000. Non-linear pharmacokinetics of MDMA (ecstasy) in humans. Br. J. Clin. Pharmacol. 49: 104–109.
   PubMed Web of Science ®Google Scholar
• De Souza, I., Kelly, J. P., Harkin, A. J., and Leonard, B. E. 1997. An appraisal of the pharmacological and toxicological effects of a single oral administration of 3,4-methylenedioxy-methamphetamine (MDMA) in the rat. Pharmacol. Toxicol 80: 207–210.
   PubMedGoogle Scholar
• Esteban, B., O’Shea, E., Camarero, J., Sanchez, V., Green, A. R., and Colado, M. I. 2001. 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose. Psychopharmacology 154: 251–260.
   PubMed Web of Science ®Google Scholar
• Feldman, K. W., and Mazor, S. 2007. Ecstasy ingestion causing heatstroke-like, multiorgan injury in a toddler. Pediatr. Emerg. Care 23: 725–726.
   PubMedGoogle Scholar
• Fitzgerald, R. L., Blanke, R. V., Rosecrans, J. A., and Glennon, R. A. 1989. Stereochemistry of the metabolism of MDMA to MDA. Life Sci. 45: 295–301.
   PubMed Web of Science ®Google Scholar
• Frith, C. H., Chang, L. W., Lattin, D. L., Walls, R. C., Hamm, J., and Doblin, R. 1987. Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the rat. Fundam. Appl. Toxicol. 9: 110–119.
   PubMedGoogle Scholar
• Gad, S. C. 2001. Statistics for toxicologists. In Principles and methods of toxicology, 4th ed., ed. A. W. Hayes, 285–364. Philadelphia, PA: Taylor & Francis.
   Google Scholar
• Greer, G., and Strassman, R. J. 1985. Information on “ecstasy.” Am. J. Psychiatry 142: 1391.
   PubMed Web of Science ®Google Scholar
• Grinspoon, L., and Bakalar, J. B. 1986. Can drugs be used to enhance the psychotherapeutic process? Am. J. Psychother. 40: 393–404.
   PubMed Web of Science ®Google Scholar
• Halpern, P., Moskovich, J., Avrahami, B., Bentur, Y., Soffer, D., and Peleg, K. 2011. Morbidity associated with MDMA (ecstasy) abuse: A survey of emergency department admissions. Hum. Exp. Toxicol. 30: 259–266.
   PubMed Web of Science ®Google Scholar
• Hardman, H. F., Haavik, C. O., and Seevers, M. H. 1973. Relationship of the structure of mescaline and seven analogs to toxicity and behaviour in five species of laboratory animals. Toxicol. Appl.Pharmacol. 25: 299–309.
   PubMed Web of Science ®Google Scholar
• Hegadoren, K. M., Baker, G. B., and Bourin, M. 1999. 3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans. Neurosci. Biobehav. Rev. 23: 539–553.
   PubMed Web of Science ®Google Scholar
• In, S. W., Son, E. W., Rhee, D. K., and Pyo, S. 2005. Methamphetamine administration produces immunomodulation in mice. J. Toxicol. Environ. Health A 68: 2133–2145.
   PubMed Web of Science ®Google Scholar
• Liechti, M. E., and Vollenweider, F. X. 2000. Acute psychological and physiological effects of MDMA (“ecstasy”) after haloperidol pretreatment in healthy humans. Eur. Neuropsychopharmacol. 10: 289–295.
   PubMed Web of Science ®Google Scholar
• Malpass, A., White, J. M., Irvine, R. J., Somogyi, A. A., and Bochner, F. 1999. Acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA) in Sprague-Dawley and Dark Agouti rats. Pharmacol. Biochem. Behav. 64: 29–34.
   PubMed Web of Science ®Google Scholar
• Milroy, C. M., Clark, J. C., and Forrest, A. R. 1996. Pathology of deaths associated with ecstasy and eve misuse. J. Clin. Pathol. 49: 149–153.
   PubMed Web of Science ®Google Scholar
• Morgan, M. J. 2000. Ecstasy (MDMA): A review of its possible persistent psychological effects. Psychopharmacology 152: 230–248.
   PubMed Web of Science ®Google Scholar
• O’Cain, P. A., Hletko, S. B., Ogden, B. A., and Varner, K. J. 2000. Cardiovascular and sympathetic responses and reflex changes elicited by MDMA. Physiol. Behav. 70: 141–148.
   PubMed Web of Science ®Google Scholar
• Parrott, A. C., and Stuart, M. 1997. Ecstasy (MDMA), amphetamine and LSD: Comparative mood profiles in recreational poly-drug users. Hum. Psychopharmacol. 12: 501–504.
   Web of Science ®Google Scholar
• Paumgartten, F. J. 2010. Influence of maternal toxicity on the outcome of developmental toxicity studies. J. Toxicol. Environ. Health A 73: 944–951.
   PubMed Web of Science ®Google Scholar
• Perfetti, X., O’Mathúna, B., Pizarro, N., Cuyàs, E., Khymenets, O., Almeida, B., Pellegrini, M., Pichini, S., Lau, S. S., Monks, T. J., Farré, M., Pascual, J. A., Joglar, J., and de la Torre, R. 2009. Neurotoxic thioether adducts of 3,4-methylenedioxymethamphetamine identified in human urine after ecstasy ingestion. Drug Metab. Dispos. 37: 1448–1455.
   PubMed Web of Science ®Google Scholar
• Peroutka, S. J., Newman, H., and Harris, H. 1988. Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 1: 273–277.
   PubMed Web of Science ®Google Scholar
• Plessinger, M. A. 1998. Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy. Obstet. Gynecol.Clin. North Am. 25: 119–138.
   PubMed Web of Science ®Google Scholar
• Rezvani, A. H., Garges, P. L., Miller, D. B., and Gordon, C. J. 1992. Attenuation of alcohol consumption by MDMA (ecstasy) in two strains of alcohol-preferring rats. Pharmacol. Biochem. Behav. 43: 103–110.
   PubMed Web of Science ®Google Scholar
• Ricaurte, G. A., Bryan, G., Strauss, L., Seiden, L., and Schuster, C. 1985. Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science 229: 986–988.
   PubMed Web of Science ®Google Scholar
• Rochester, J. A., and Kirchner, J. T. 1999. Ecstasy (3,4-methylenedioxymethamphetamine): History, neurochemistry, and toxicology. J. Am. Board. Family Pract. 12: 137–142.
   PubMedGoogle Scholar
• Sarpa, M., Tavares Lopes, C. M., Delgado, I. F., and Paumgartten, F. J. 2010. Postnatal development and fertility of offspring from mice exposed to triphenyltin (fentin) hydroxide during pregnancy and lactation. J. Toxicol. Environ. Health A 73: 965–971.
   PubMed Web of Science ®Google Scholar
• Sharma, H. S., and Ali, S. F. 2008. Acute administration of 3,4-methylenedioxymeth-amphetamine induces profound hyperthermia, blood–brain barrier disruption, brain edema formation, and cell injury. Ann. NY Acad. Sci. 1139: 242–258.
   PubMed Web of Science ®Google Scholar
• Shulgin, A. T., and Nichols, D. E. 1978. Characterization of three new psychomimetics. In The psychopharmacology of hallucinogens, ed. R. C. Stillman and R. E. Willette, 74–83. Oxford, UK: Pergamon Press.
   Google Scholar
• Silva Nunes, M. F., da Silva Nunes, R., Silva Kahl, V. F., Moysés Reyes, J., and da Silva, J. 2013. Use of buccal micronucleus assay to determine mutagenicity induced by amfepramone in humans and the protective effects of vitamin C. J. Toxicol. Environ. Health A 76: 1121–1128.
   PubMed Web of Science ®Google Scholar
• Sleiman, H. K., Romano, R. M., Oliveira, C. A., and Romano, M. A. 2013. Effects of prepubertal exposure to silver nanoparticles on reproductive parameters in adult male Wistar rats. J. Toxicol. Environ. Health A 76: 1023–1032.
   PubMed Web of Science ®Google Scholar
• Slikker, W. Jr., Holson, R. R., Ali, S. F., Kolta, M. G., Paule, M. G., Scallet, A. C., McMillan, D. E., Bailey, J. R., Hong, J. S., and Scalzo, F. M. 1989. Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate. Neurotoxicology 10: 529–542.
   Google Scholar
• Sun, K., Lu, J., Jiang, Y., Xu, M., Xu, Y., Zhang, J., Xu, B., Sun, J., Sun, W., Ren, C., Liu, J., Wang, W., Bi, Y., and Ning, G. 2014. Low serum potassium level is associated with nonalcoholic fatty liver disease and its related metabolic disorders. Clin. Endocrinol. (Oxford) 80: 348–355.
   PubMed Web of Science ®Google Scholar
• Taylor, M., Lau, B. P., Feng, S. Y., Bourque, C., Buick, J. K., Bondy, G. S., and Cooke, G. M. 2013. Effects of oral exposure to arsenobetaine during pregnancy and lactation in Sprague-Dawley rats. J. Toxicol. Environ. Health A 76: 1333–1345.
   PubMed Web of Science ®Google Scholar
• Wilson, J. G. 1965. Methods for administering agents and detecting malformations in experimental animals. In Teratology principles and techniques, ed. J. G. Wilson and J. Warkany, 262–277. Chicago, IL: University of Chicago Press.
   Google Scholar
• Winslow, J. T., and Insel, T. R. 1991. Serotonergic modulation of the rat pup ultrasonic isolation call: Studies with 5-HT1 and 5-HT2 subtype-selective agonists and antagonists. Psychopharmacology 105: 513–520.
   PubMed Web of Science ®Google Scholar
• Ziporyn, T. 1986. A growing industry and menace: Makeshift laboratory’s designer drugs. J. Am. Med. Assoc. 256: 3061–3063.
   PubMed Web of Science ®Google Scholar